Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia
· Delayed Price · Currency is AUD 0.270
-0.025 (-8.47%)
Mar 9, 2026, 2:07 PM AEST
ASX:LDX Revenue
Lumos Diagnostics Holdings had revenue of $6.12M USD in the half year ending December 31, 2025, with 121.26% growth. This brings the company's revenue in the last twelve months to $12.21M, down -16.75% year-over-year. In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M with 11.40% growth.
Revenue (ttm)
$12.21M
Revenue Growth
-16.75%
P/S Ratio
12.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
235.32M AUD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aroa Biosurgery | 79.26M |
| Epiminder | 648.18K |
| EMVision Medical Devices | 5.43M |
| SomnoMed | 118.50M |
| PolyNovo | 139.49M |
| Cleo Diagnostics | 2.56M |
| Anteris Technologies Global | 2.87M |
| Compumedics | 58.49M |